AGU 100.48 Agrium Inc $AGU Hit a 52 week high of 101.23

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
AGU 100.48 Agrium Inc $AGU Hit a 52 week high of 101.23 Closing the day 09:45 at 100.48 -0.23 -0.23% With a day low of 100.48 and a total volume of 19,817.

AGU Recent Posts: http://investorshangout.com/Agrium-Inc-AGU-50038/

AGU Agrium Inc Recent Headline News

Stock Watchout on Chemicals Industry - Mosaic, Agrium, Intrepid Potash, CF Industries Holdings, and Methanex
PR Newswire - Tue Nov 11, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: The Mosaic Company (NYSE: MOS), Agrium Inc. (NYSE: AGU), Intrepid Potash Inc. (NYSE: IPI), CF Industries Holdings Inc. (NYSE: CF), and Methanex Corporation (NASDAQ: MEOH). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 10, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,613.74, up 0.23% and the NASDAQ Composite closed at 4,651.62, up 0.41%. The S&P 500 finished the session 0.31% higher at 2,038.26. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 306.58, up 0.26%, with the index advancing 5.11% in the last one month. Register for your complimentary reports on these five stocks at:
CF: 267.00 (+0.62), AGU: 100.48 (-0.23), MOS: 45.40 (+0.23), IPI: 13.93 (+0.03), MEOH: 57.27 (-0.04)

Agrium (AGU) Unit to Acquire Equity Stake in CH Biotech - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 6:05PM CST
Agrium's (AGU) subsidiary Loveland Products has agreed to purchase an equity interest in CH Biotech.
CF: 267.00 (+0.62), AGU: 100.48 (-0.23), MOS: 45.40 (+0.23), POT: 33.67 (-0.10)

10 Stocks Providing Positive Feedback With Increased Dividends
Dividends4Life - at Seeking Alpha - Fri Nov 07, 5:40PM CST

VVC: 45.00 (-0.47), HON: 97.64 (+0.63), AGU: 100.48 (-0.23), AFSI: 52.91 (+1.17), SEP: 55.95 (-0.79), CLNY: 24.64 (-0.04), ATO: 53.76 (-0.14), OZM: 11.82 (+0.11), MCY: 55.30 (+0.16), ROK: 110.52 (-1.92)

CF Industries Misses Earnings and Revenue Estimates in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 11:20AM CST
CF Industries (CF) reported a roughly 44% fall in its profit in third-quarter 2014 to $130.9 million or $2.62 per share from $234.1 million or $4.07 per share a year ago, hurt by a double-digit fall in its sales.
CF: 267.00 (+0.62), AGU: 100.48 (-0.23), MOS: 45.40 (+0.23), POT: 33.67 (-0.10)

Agrium agrees for an equity stake in CH Biotech
M2 - Thu Nov 06, 4:49AM CST
Agricultural company Agrium (TSX:AGU.TO) (NYSE:AGU) said on Wednesday that its Loveland Products subsidiary has announced a definitive agreement for an equity stake in CH Biotech, an agricultural technology company.
AGU: 100.48 (-0.23)

A Bigger Payday For Owners Of These 6 Dividend Growers
James Jenckes - at Seeking Alpha - Wed Nov 05, 5:25PM CST

SBUX: 78.17 (+0.32), SE: 38.25 (-0.71), HON: 97.64 (+0.63), AGU: 100.48 (-0.23), EMR: 63.93 (-0.12), EL: 72.60 (-0.02)

Agrium Agrees to Take Equity Stake in CH Biotech R&D
Marketwired - Wed Nov 05, 1:45PM CST
Agrium Inc. (TSX: AGU) (NYSE: AGU), through its subsidiary Loveland Products, Inc., and CH Biotech R&D Co., Ltd. ("CH Biotech" , an agricultural technology company that develops and markets plant health and nutrition technologies, today announced that Loveland Products has signed a definitive agreement to take an equity stake in CH Biotech. Under the terms of the agreement, Agrium will have the right to obtain exclusive, worldwide distribution rights to CH Biotech's existing plant health technologies as well as access to new product and technology opportunities. It will also allow CH Biotech to further collaborate with Agrium to expand their plant health-focused research and development initiatives.
AGU.TO: 113.89 (-0.23), AGU: 100.48 (-0.23)

Agrium's (AGU) CEO Charles Magro on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 2:50PM CST

AGU: 100.48 (-0.23)

Agrium Misses Earnings Estimates in Q3, Hikes Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:30AM CST
Agrium Inc. (AGU) posted profit from continuing operations of $91 million or 63 cents per share in the third quarter of 2014, a rise of around 13.8% from $80 million or 54 cents per share registered a year ago.
CF: 267.00 (+0.62), AGU: 100.48 (-0.23), POT: 33.67 (-0.10)

Agrium (AGU) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 10:25AM CST

AGU: 100.48 (-0.23)

Update: Agrium - A Call For Patience
Price Point - at Seeking Alpha - Tue Nov 04, 9:23AM CST

AGU: 100.48 (-0.23)

Agrium beats by $0.13, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:34PM CST

AGU: 100.48 (-0.23)

Agrium declares $0.78 dividend
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:34PM CST

AGU: 100.48 (-0.23)

Agrium Announces Third Quarter Results and Dividend Increase
Marketwired - Mon Nov 03, 5:33PM CST
ALL AMOUNTS ARE STATED IN U.S.$
AGU.TO: 113.89 (-0.23), AGU: 100.48 (-0.23)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST

RKT: 56.00 (+0.06), HLF: 37.71 (-0.10), EGAN: 5.25 (-0.09), CUTR: 10.37 (-0.03), DXPE: 68.11 (-0.02), AEIS: 20.63 (-0.06), NOR: 4.06 (+0.02), KBR: 19.06 (-0.03), SGY: 22.44 (-0.24), RTEC: 9.12 (+0.07), PKT: 7.08 (+0.13), OGS: 38.71 (-0.24), BKH: 55.27 (-0.54), KAMN: 41.56 (+0.04), EOX: 2.89 (-0.02), MR: 31.52 (+0.03), RKUS: 12.29 (-0.24), LCI: 50.55 (+0.82), NBIX: 19.34 (+0.06), PQ: 3.96 (-0.05), RBC: 71.51 (+0.04), CHGG: 6.95 (+0.02), AIG: 54.43 (+0.08), MRO: 32.26 (-0.39), GRT: 13.86 (+0.05), EPAM: 48.05 (+0.26), CKP: 13.18 (-0.01), SBRA: 28.11 (+0.19), MDU: 25.33 (-0.09), NTRI: 18.32 (+0.24), ELNK: 4.37 (unch), EQC: 26.00 (+0.24), CVD: 100.67 (-0.06), IART: 48.24 (+0.01), FN: 17.78 (-0.19), APL: 33.26 (-0.04), BDE: 9.09 (+0.10), AGU: 100.48 (-0.23), PLOW: 23.70 (+0.04), REG: 61.57 (+0.26), QLYS: 36.40 (+0.41), GALE: 1.92 (unch), ANV: 1.16 (+0.03), ININ: 48.20 (+0.31), FTR: 6.78 (unch), GTY: 18.52 (+0.06), MCEP: 16.84 (+0.31), CYH: 46.58 (-0.27), SKH: 7.10 (+0.06), ACXM: 19.03 (-0.29), PL: 69.97 (unch), RLD: 11.70 (+0.02), CXW: 36.20 (+0.11), SALE: 14.84 (+0.02), ENH: 57.83 (+0.03), CRK: 11.85 (-0.31), AMTG: 16.29 (+0.04), OTTR: 30.10 (-0.05), NLS: 14.68 (+0.04)

Agrium (AGU) Enters Overbought Territory

Agrium Inc. (AGU) Stock Research Links

AGU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 25

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Boussard & Gavaudan's NAV Report Highlights for Investors

Updated Category News Views 72

Boussard & Gavaudan Holding Limited: NAV Update Boussard & Gavaudan Holding Limited is pleased to provide a recent update regarding the company's net asset values (NAV) for its Ordinary Shares. Investors are encouraged to stay informed about the performance and returns associated with their investments. Current NAV Estimates The estimated NAV, as of the close of business,...

Continue Reading
Moab Launches Free Shuttle to Enhance Park Access

Updated Category News Views 11

Moab's Shuttle: A New Era for Park Access A breeze of change is sweeping through the dusty trails of Moab, Utah, and this isn't just any switch—it's about making the always-packed Arches National Park a bit less of a traffic nightmare. Imagine this: strolling up to a shuttle, no tickets, no cash needed, and you're off to see epic scenery like The Windows and Delicate...

Continue Reading
Grid Dynamics Shares Upcoming Financial Results Preview

Updated Category News Views 82

Overview of Upcoming Financial Results Announcement Grid Dynamics Holdings, Inc. (Nasdaq: GDYN), recognized as a frontrunner in the digital transformation sector, is preparing to announce its financial results for the fourth quarter and full year of the fiscal year 2024. This much-anticipated event is scheduled for February 20, 2025. Investors and stakeholders can look...

Continue Reading
BioSig Technologies and Streamex Successfully Close $15 Million Offering

Updated Category News Views 154

BioSig Technologies and Streamex Close $15 Million Offering BioSig Technologies, Inc. is excited to share that it has successfully completed a public offering, raising approximately $15 million. The company, now merged with Streamex Exchange Corporation (NASDAQ: BSGM), focuses on gold tokenization infrastructure, positioning itself as a leader in the industry. Details of...

Continue Reading
Navigate Wellbeing Solutions Achieves 2024 Workplace Excellence

Updated Category News Views 64

Navigating Towards Employee Satisfaction Navigate Wellbeing Solutions has proudly secured the Great Place To Work Certification™ for the year 2024. This recognition is a testament to the positive work environment fostered by the organization, as revealed by feedback from employees. An impressive 92% of team members agree it's a great place to work, significantly above...

Continue Reading